Not exact matches
Based on our knowledge of the flu virus and the human immune system, we can
use computers to
design the components of a
vaccine that gives much broader and longer - lasting protection.»
«Our ability to control these reactions and
use them to form a response to the
vaccine will be critical in
designing the next generation of
vaccines,» Kemble says.
Unlike any other
vaccine designed for human
use, this product would be a DNA
vaccine that only contains a particular part of the pathogen (rather than a
vaccine with an inactivated live or dead virus, for example).
Flu
vaccines are
designed to prevent infection by eliciting antibodies against HA, which the virus
uses to break into cells lining the airways.
We are looking for the proteins that make the tumour cells different to the host devils that they infect and then
use these «tumour specific» proteins to
design a
vaccine that will save the devil from extinction.
To create a new dengue virus
vaccine, Stefan Metz, Shaomin Tian in the laboratories of Aravinda de Silva, Chris Luft and Joe DeSimone at the University of Carolina, Chapel Hill, USA
designed nanoparticles of various shapes and sizes
using Particle Replication in Non-wetting Template (PRINT) technology.
«We think we can
use our molecular, rational
design approaches to make a better flu
vaccine for people who really need it,» says study leader Andrew Pekosz, PhD, an associate professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health.
Thanks to # 183,759 funding from the Leverhulme Trust to the University, Dr Siddle will lead a three - year research project to understand how the disease moves between the animals and then
use this information to
design a
vaccine against the tumour.
Using the findings from this study, the team has
designed vaccine immunogens to selectively trigger the cooperating antibody - producing B cells to cooperate to make broadly neutralizing antibodies in a manner that mimics broadly neutralizing antibody development in natural HIV infection.
Kang's primary research focuses on
designing and developing effective
vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be
used to improve health and protect against disease because of the potential benefit in fighting these viruses.
The ability to
design new protein nanostructures could have useful implications in targeted delivery of drugs, in
vaccine development and in plasmonics — manipulating electromagnetic signals to guide light diffraction for information technologies, energy production or other
uses.
Global
vaccine experts and officials from all 26 African «meningitis belt» countries have convened in Addis Ababa, Ethiopia to celebrate one of Africa's biggest public health achievements — the introduction of a
vaccine, MenAfriVac ®,
designed, developed, and produced for
use in Africa, that in five years of
use has nearly eliminated serogroup A meningococcal disease from meningitis belt countries and is now being integrated into routine national immunization programs.
Wang and collaborators
designed a
vaccine candidate
using an HIV protein fragment linked to a sugar group.
Using this knowledge, Andino's team has
designed a
vaccine that should be less likely to go through these steps.
A critical implication of this work for the field of HIV
vaccine design is the observation that the most potent and broad individual anti-HIV VHH, J3, was elicited in response to the gp140 immunogens
used.
Working with a world - leading group at the University of Connecticut in the USA, who pioneered the development of self - assembling protein nanoparticles (SAPNs) for
vaccine design, they have
used advanced mathematical calculations to create a complete picture of the surface morphology of these particles.
Now as an Assistant Professor in Medicine at Harvard Medical School, Daniel
uses membrane structure and function as a means to define B cell antigen recognition and inform
vaccine design.
GLS - 5700, which was
designed and tested in seven months, differs from conventional
vaccines, which typically
use inactivated or killed versions of a virus and can take years to develop and test.
As a part of VIOLIN, we have developed Vaxign, the first web - based publically available
vaccine target
design tool based on bioinformatics analysis of genome sequences
using the strategy of reverse vaccinology.
A key program of VIOLIN is Vaxign, the first web - based publically available
vaccine target
design tool based on bioinformatics analysis of genome sequences
using the strategy of reverse vaccinology.
«This is a straightforward study of the
use of two established
vaccine technologies in an attempt to
design and test new Zika
vaccines.
«The promising results show that personalised cancer
vaccines designed to treat skin cancer are safe to
use, and that for some patients, they can successfully harness the power of the body's own immune system to kill cancer cells,» Pickworth added.
Using enhanced DNA technology, the lab has
designed DNA
vaccines that drive immune responses in prophylactic or therapeutic settings against Human Immunodeficiency Virus (HIV), Dengue (DV), Chikungunya virus (CHIKV), Middle Eastern Respiratory Syndrome (MERS) virus, and Zika Virus (ZV).
Researchers
used unique differences in each patient's cancer to
design vaccines to spur the immune system into action.
The space was also
designed with the public in mind, featuring interactive tour stops throughout the lab space that
use technology to underscore IDRI's work in developing
vaccines, drugs and diagnostics, as well as large built - in windows to showcase IDRI's specialized facilities, including manufacturing.
IAVI launched the Neutralizing Antibody Consortium (NAC) in 2002 to study the molecular structure and biochemistry of known broadly neutralizing antibodies and to
use this information to
design (reverse engineer) potentially powerful AIDS
vaccine candidates.
That may mean saying no to your vet or, preferably, it means finding a vet who is paying attention to the damage
vaccines can cause and is
using vaccines (or not
using them) to do what they were
designed to do: protect your dog!
The two - dose inactivated
vaccine, licensed for
use in healthy pregnant sows and gilts, is
designed to help them develop antibodies that can be transmitted to their newborn piglets.
We
design a personalized
vaccine protocol for each dog, maximizing protection against the diseases your pet is likely to be exposed to while
using the fewest
vaccines possible.
We
design a personalized
vaccine protocol for each cat, maximizing protection against the diseases your cat is likely to be exposed to while
using the fewest
vaccines possible.
Vaccines Vaccine protocols are designed specifically for each individual patient using the most current information and vaccines av
Vaccines Vaccine protocols are
designed specifically for each individual patient
using the most current information and
vaccines av
vaccines available.
In addition to the preceding program, a few years ago I began
using an intranasal (ocular - nasal)
vaccine designed to be dropped in the eyes and nose.
In order to help prevent or treat any of these reactions, FloridaWild
uses only Merial
vaccines designed for ferrets.
develops autonomous drones
designed to deliver
vaccines, medicine and blood on request from health workers in rural areas, with the Tanzanian government to begin
using more than 100 drones from four distribution centers to make up to 2,000 deliveries each day.
Zipline develops autonomous drones
designed to deliver
vaccines, medicine and blood on request from health workers in rural areas, with the Tanzanian government to begin
using more than 100 drones from four distribution centers to make up to 2,000 deliveries each day.
Guided by the Behavioral
Vaccine Theory of prevention, this study
uses a no - control group
design to examine intervention variables that predict favorable changes in depressive symptoms at the six - to - eight week follow - up in at - risk adolescents who participated in a primary care, Internet - based prevention program.